These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9701451)

  • 1. Anticoagulant effects of synthetic retinoids and activated vitamin D3.
    Koyama T; Hirosawa S
    Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant effects of synthetic retinoids.
    Koyama T; Shibakura M
    Leuk Lymphoma; 1998 Sep; 31(1-2):71-80. PubMed ID: 9720716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant effects of synthetic retinoids mediated via different receptors on human leukemia and umbilical vein endothelial cells.
    Shibakura M; Koyama T; Saito T; Shudo K; Miyasaka N; Kamiyama R; Hirosawa S
    Blood; 1997 Aug; 90(4):1545-51. PubMed ID: 9269772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant effects of retinoic acids on leukemia cells.
    Saito T; Koyama T; Nagata K; Kamiyama R; Hirosawa S
    Blood; 1996 Jan; 87(2):657-65. PubMed ID: 8555488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant effects of 1alpha,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes.
    Koyama T; Shibakura M; Ohsawa M; Kamiyama R; Hirosawa S
    Blood; 1998 Jul; 92(1):160-7. PubMed ID: 9639512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction pathways underlying the expression of tissue factor and thrombomodulin in promyelocytic cells induced to differentiate by retinoid acid and dibutyryl cAMP.
    López-Pedrera C; Dobado-Berrios PM; Ros R; Torres A; García-Navarro S; Jardí M; Félez J; Velasco F
    Thromb Haemost; 2001 Jun; 85(6):1031-6. PubMed ID: 11434680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
    Zhuang Y; Faria TN; Chambon P; Gudas LJ
    Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
    Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
    Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
    Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promyelocytic leukemia retinoid signaling targets regulate apoptosis,tissue factor and thrombomodulin expression.
    López-Pedrera C; Barbarroja N; Buendía P; Torres A; Dorado G; Velasco F
    Haematologica; 2004 Mar; 89(3):286-95. PubMed ID: 15020266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retinoid signalling pathways].
    Fukasawa H; Shudo K
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative action of 1alpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled.
    Bastie JN; Balitrand N; Guillemot I; Chomienne C; Delva L
    Exp Cell Res; 2005 Nov; 310(2):319-30. PubMed ID: 16181625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
    Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
    Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells.
    Koyama T; Hirosawa S; Kawamata N; Tohda S; Aoki N
    Blood; 1994 Nov; 84(9):3001-9. PubMed ID: 7949172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
    Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
    Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of thrombomodulin antigen levels in U937 cells by combined stimulation with estradiol-17beta and vitamin K2 (menaquinone 4).
    Nishiguchi T; Kobayashi T; Sugimura M; Kobayashi H; Terao T
    Semin Thromb Hemost; 1999; 25(5):509-17. PubMed ID: 10625211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different combinations of retinoids and vitamin D3 analogs efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines.
    Defacque H; Dornand J; Commes T; Cabane S; Sevilla C; Marti J
    J Pharmacol Exp Ther; 1994 Oct; 271(1):193-9. PubMed ID: 7965714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
    Géhin M; Vivat V; Wurtz JM; Losson R; Chambon P; Moras D; Gronemeyer H
    Chem Biol; 1999 Aug; 6(8):519-29. PubMed ID: 10421757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.